» Articles » PMID: 21543163

Computed Tomography Appearance of Early Radiation Injury to the Lung: Correlation with Clinical and Dosimetric Factors

Overview
Specialties Oncology
Radiology
Date 2011 May 6
PMID 21543163
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To systematically assess the spectrum of radiologic changes in the lung after radiation therapy for non-small-cell lung cancer.

Methods And Materials: We reviewed the cases of 146 patients treated with radical radiotherapy at our institution. All patients had computed tomography (CT) scans performed 3 months after completion of therapy. Radiographic appearances were categorized using a standard grading system. The association of these abnormalities with pretreatment factors and clinical radiation pneumonitis (RP) was investigated.

Results: New intrapulmonary abnormalities were seen in 92 patients (63%). These were ground-glass opacity in 16 (11%), patchy consolidation in 19 (13%), and diffuse consolidation in 57 (39%). Twenty-five patients (17%) developed clinical symptoms of RP. Although 80% of the patients with RP had areas of consolidation seen on the posttreatment CT scan, the majority (74%) of patients with such radiographic changes were asymptomatic. For patients with lung infiltrates, the minimum isodose encompassing the volume of radiologic abnormality was usually ≥27 Gy. Traditional dose-volume metrics, pulmonary function tests, and the coadministration of angiotensin converting enzyme inhibitors (ACE-I) were all strongly correlated with the presence of radiologic injury on univariate analysis (p≤0.002). There was also an inverse correlation between prior smoking history and CT scan changes (p=0.02). On multivariate analysis, dosimetric parameters and the use of ACE-I retained significance (p=0.005).

Conclusions: Our findings suggest that there is substantial interindividual variation in lung radiosensitivity. ACE-I prevented the radiologic changes seen after high-dose radiation therapy, and their role as radioprotectants warrants further investigation.

Citing Articles

The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis.

Liao W, Shokr H, Faivre-Finn C, Dempsey C, Williams K, Chen L Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861167 PMC: 11769270. DOI: 10.3390/ph18010105.


Exploring the effects of Qijiao Shengbai capsule on leukopenic mice from the perspective of intestinbased on metabolomics and 16S rRNA sequencing.

Cao Y, Zhang S, Tang L, Chen Y, Jiang S, Liu L Heliyon. 2023; 9(9):e19949.

PMID: 37810141 PMC: 10559567. DOI: 10.1016/j.heliyon.2023.e19949.


Lack of dose dependency for radiation pneumonitis after chemoradiotherapy with the use of tomotherapy for lung cancer.

Masuoka Y, Tada T, Tokunaga M, Takeshita N, Terashima M, Tsutsumi S Nagoya J Med Sci. 2022; 84(1):180-184.

PMID: 35392013 PMC: 8971034. DOI: 10.18999/nagjms.84.1.180.


Radiation-Induced Lung Injury-Current Perspectives and Management.

Rahi M, Parekh J, Pednekar P, Parmar G, Abraham S, Nasir S Clin Pract. 2021; 11(3):410-429.

PMID: 34287252 PMC: 8293129. DOI: 10.3390/clinpract11030056.


High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.

Szejniuk W, Nielsen M, Takacs-Szabo Z, Pawlowski J, Al-Saadi S, Maidas P Radiat Oncol. 2021; 16(1):131.

PMID: 34266462 PMC: 8281688. DOI: 10.1186/s13014-021-01857-8.